वल्वा या वेजाइनल कैंसर
Clinical Outcomes and Quality of Life in Patients With Locally Advanced Vulvovaginal Cancers: Ambispective Registration Study.
कहाँ जाना है
इस trial के लिए 1 hospital भारत में मरीज़ ले रहा है।
रजिस्ट्री समरी (तकनीकी)
The vaginal cancers are responsible for 2% of gynecological cancer while vulvar cancers account for 4 % of gynecological cancers. HPV 16 and 33 are most prevalent in vaginal cancers and account for more than half of cases HPV related vaginal cancer. However, adeqaute information is not there. Similarly, structured QOL data is not available for India. Therefore, in the proposed study we will like to systematically evaluate the patterns of relapse and disease outcomes in patients with vulvovaginal cancer treated with radiation (+/- chemotherapy). The therapeutic research in vulvo-vaginal cancers…
स्पॉन्सर: टाटा मेमोरियल हॉस्पिटल
ClinicalTrials.gov पर NCT07179757
रजिस्ट्री में आखिरी बार 4 फरवरी 2026 को अपडेट किया गया · हमने 20 अक्टूबर 2026 को पढ़ा